Orientoxin Biotech

Orientoxin Biotech is a specialized biotechnology company focused on the discovery and development of novel therapeutics derived from animal venoms and toxins. Leveraging a proprietary platform for the identification and optimization of bioactive peptides, the company targets ion channels and G protein-coupled receptors (GPCRs) to address unmet needs in pain management, epilepsy, and autoimmune disorders. Orientoxin maintains an extensive library of natural toxins and utilizes advanced recombinant expression and chemical synthesis technologies to create highly selective drug candidates. The company's research aims to harness the high potency and specificity of venom-derived molecules while minimizing off-target effects common in traditional small molecule therapies.